N-Acetylneuraminic Acid Phosphatase (NANP)

Reference work entry


N-acetylneuraminate 9-phosphate phosphatase (NANP) catalyzes the reaction: N-acetylneuraminic acid 9-phosphate (Neu5Ac-9-P)→N-acetylneuraminic acid (Neu5Ac) + phosphate. This enzyme is necessary only in animals. Neu5Ac-9-P, but not Neu5Ac, is the product of the condensation reaction of N-acetylmannosamine 6-phosphate (ManNAc-6-P) with phosphoenolpyruvate (PEP), catalyzed by the Neu5Ac-9-P synthase (NANS) in animals. Dephosphorylation of Neu5Ac-9-P by this enzyme is necessary to produce free Neu5Ac. In bacteria, Neu5Ac is directly synthesized from ManNAc and PEP, and no NANP is necessary. In animals Neu5Ac cannot be synthesized from ManNAc by the NANP. The NANP gene has not been reported in bacteria, although there reported the similar dephosphorylation enzyme, Kdo (2-keto-3-deoxy-D-manno-octurosonic acid) 8-phosphate phosphatase that is involved in the synthesis of Kdo in bacteria and plants, but not in animals. Interestingly, a human symbiont Bacteroides thetaiotaomicron has the 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid 9-phosphate (Kdn-9-P) phosphatase, which catalyzes the reaction: Kdn-9-P→Kdn + phosphate.


Sialic Acid Aspartic Acid Residue Enzyme Fraction Distal Myopathy Gene Target Experiment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Angata T, Nakata D, Matsuda T, Kitajima K, Troy FA II (1999) Biosynthesis of KDN (2-keto-3-deoxy-D-glycero-D-galacto-nononic acid). J Biol Chem 274:22949–22956PubMedCrossRefGoogle Scholar
  2. Collet JF, Stroobant V, Pirard M, Delpierre G, Van Schaftingen E (1998) A new class of phosphotransferases phosphorylated on an aspartate residue in an amino-terminal DXDX(T/V) motif. J Biol Chem 273:14107–14112PubMedCrossRefGoogle Scholar
  3. Go S, Sato C, Furuhata K, Kitajima K (2006) Oral ingestion of mannose alters the expression level of deaminoneuraminic acid (KDN) in mouse organs. Glycoconj J 23:411–421PubMedCrossRefGoogle Scholar
  4. Go S, Sato C, Yin J, Kannagi R, Kitajima K (2007) Hypoxia-enhanced expression of free deaminoneuraminic acid in human cancer cells. Biochem Biophys Res Commun 357:537–542PubMedCrossRefGoogle Scholar
  5. Jourdian GW, Swanson AL, Watson D, Roseman S (1964) Isolation of sialic acid 9-phosphate phosphatase from human erythrocytes. J Biol Chem 239:PC2714–PC2716PubMedGoogle Scholar
  6. Lu Z, Wang L, Dunaway-Mariano D, Allen KN (2009) Structure-function analysis of 2-keto-3-deoxy-D-glycero-D-galacto-nononate-9-phosphate phosphatase defines specificity elements in Type C0 haloalkanoate dehalogenase family member. J Biol Chem 284:1224–1233PubMedCrossRefGoogle Scholar
  7. Maliekal P, Vertommen D, Delpierre G, Van Schaftingen E (2006) Identification of the sequence encoding N-acetylneuraminate-9-phosphate phosphatase. Glycobiology 16(2):165–172PubMedCrossRefGoogle Scholar
  8. McClard RW (1979) Synthesis and purification of [L-32P]fructose-1,6-bisphosphate with high specific radioactivity. Anal Biochem 96:500–513PubMedCrossRefGoogle Scholar
  9. Malicdan MC, Noguchi S, Nonaka I, Hayashi YK, Nishino I (2007) A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Hum Mol Genet 16:2669–2682PubMedCrossRefGoogle Scholar
  10. Nakata D, Close BE, Colley KJ, Matsuda T, Kitajima K (2000) Molecular cloning and expression of the mouse N-acetylneuraminicacid 9-phosphate synthase which does not have deaminoneuraminic acid (KDN) 9-phosphate synthase activity. Biochem Biophys Res Commun 273:642–648PubMedCrossRefGoogle Scholar
  11. Nakata D, Munster AK, Gerardy-Schahn R, Aoki N, Matsuda T, Kitajima K (2001) Molecular cloning of a unique CMP-sialic acid synthetase that effectively utilizes both deaminoneuraminic acid (KDN) and N-acetylneuraminic acid (Neu5Ac) as substrates. Glycobiology 11:685–692PubMedCrossRefGoogle Scholar
  12. Roseman S, Jourdian GW, Watson D, Rood R (1961) Enzymatic synthesis of sialic acid 9-phosphates. Proc Natl Acd Sci USA 47:958–961CrossRefGoogle Scholar
  13. Tajima Y, Uyama E, Go S, Sato C, Tao N, Kotani M, Hino H, Suzuki A, Sanai Y, Kitajima K, Sakuraba H (2005) Distal myopathy with rimmed vacuoles: impaired O-glycan formation in muscular glycoproteins. Am J Pathol 166:1121–1130PubMedCrossRefGoogle Scholar
  14. Ugochukwu E, Cocking R, Yue WW, Pike ACW, Roos A, Muniz JRC, Von Delft F, Bountra C, Arrowsmith CH, Weigelt J, Edwards A, Oppermann U. The crystal structure of human N-Acetylneuraminic Acid Phosphatase, Nanp. To be publishedGoogle Scholar
  15. Van Rinsum J, Van Dijk W, Hooghwinkel GJ, Ferwerda W (1984) Subcellular localization and tissue distribution of sialic acid-forming enzymes. N-acetylneuraminate-9-phosphate synthase and N-acetylneuraminate 9-phosphatase. Biochem J 223:323–328Google Scholar
  16. Wang L, Lu Z, Allen KN, Mariano P, Dunaway-Mariano D (2008) Human symbiont Bacteroides thetaiotaomicron synthesizes 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid (Kdn). Chem Biol 15:893–897PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  1. 1.Biosecience and Biotechnology CenterNagoya UniversityChikusa-kuJapan

Personalised recommendations